Robert G. Finizio, CEO, 10% Owner at TherapeuticsMD, Inc. (TXMD), sold 982,053 shares at $6.70 ($6.6M) on 2014-03-26, disclosed to the SEC on 2014-03-28.
Open-market sale of $6.6M TXMD by CEO, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |